Bill > HR796

This bill, called the "Second Chance for Moms Act of 2025", requires two main changes related to mifepristone, a medication used for medical abortions. First, it mandates that mifepristone drug labels include a prominent warning stating that the drug's effects can potentially be counteracted by natural progesterone, which might increase the chance of fetal survival. The label must also include a phone number for a specialized hotline. Second, the bill establishes a 24/7 toll-free hotline under the Public Health Service Act to provide support and information to women seeking to reverse the effects of mifepristone. The hotline can only refer callers to healthcare providers specifically offering "abortion pill reversal" services. The warning label requirement will go into effect six months after the bill's enactment, and the labeling must include language specifying that the American Society for Reproductive Medicine has determined natural progesterone is safe in the first trimester of pregnancy. This bill appears aimed at providing alternative options and information to women who have taken mifepristone and wish to potentially continue their pregnancy.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/796/all-info